Ocrelizumab associates with reduced cerebrospinal fluid B and CD20dim CD4+ T cells in primary progressive multiple sclerosis

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
48 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Ocrelizumab associates with reduced cerebrospinal fluid B and CD20dim CD4+ T cells in primary progressive multiple sclerosis'. Together they form a unique fingerprint.

Immunology and Microbiology

Neuroscience